{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:59:20Z","timestamp":1761163160680,"version":"build-2065373602"},"reference-count":37,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"vor","delay-in-days":9394,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[1986,5,6]]},"abstract":"<jats:p>Adrenal corticosteroids were first reported in 1979 to have antiemetic effects during cancer chemotherapy. Since then considerable numbers of trials have been conducted to evaluate their activity alone and in combination with other agents. The majority of the research has centered on dexamethasone, although other corticosteroids have been studied. Dexamethasone as a single agent is superior to placebo and appears to be more effective than standard doses of prochlorperazine when administered with highly emetic agents. Dexamethasone is comparable to metoclopramide against moderately emetogenic agents and low\u2010dose cisplatin, but less effective than metoclopramide against highly emetic agents or high\u2010dose cisplatin. Dexamethasone improves the activity of prochlorperazine and metoclopramide and may reduce some of the side effects associated with the latter. Current trials continue to explore the role of corticosteroids alone and in combination with antiemetics.<\/jats:p>","DOI":"10.1002\/j.1875-9114.1986.tb03465.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T18:57:15Z","timestamp":1450292235000},"page":"118-127","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adrenal Corticosteroids as Antiemetics During Cancer Chemotherapy"],"prefix":"10.1002","volume":"6","author":[{"given":"Robert J.","family":"Cersosimo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Karp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198202183060721"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.10.1170"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1981.tb02568.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808201600602"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198300251-00003"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-3-393"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(80)90027-X"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(81)90099-8"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(79)90958-1"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197909273011318"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00258206"},{"key":"e_1_2_1_13_2","first-page":"61","article-title":"The antiemetic effect and dose response of dexamethasone in patients receiving cis\u2010platinum (abstr)","volume":"1","author":"Drapkin RL","year":"1982","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_14_2","first-page":"64","article-title":"Dexamethasone (DXM) antiemesis study: a double\u2010blind clinical trial (abstr)","volume":"1","author":"Miller C","year":"1982","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.8.1133"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1983.00350070063012"},{"key":"e_1_2_1_17_2","first-page":"87","article-title":"High\u2010dose metoclopramide (MCP) versus dexamethasone (DEX) in the prevention of cis\u2010platin (CDDP) induced vomiting: a crossover randomized study (abstr)","volume":"2","author":"Frustaci S","year":"1983","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_18_2","first-page":"88","article-title":"A randomized, crossover comparison of the effectiveness of intravenous (IV) metoclopramide (MCP) and IV dexamethasone (DXM) as antiemetic prevention in cancer chemotherapy (CT) (abstr)","volume":"2","author":"McDermed JE.","year":"1983","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(84)90182-2"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.466"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198408303110901"},{"key":"e_1_2_1_22_2","first-page":"344","article-title":"Metoclopramide (MCP) vs prochlorperazine (PCP) in the prevention of vomiting from diamminedichloroplatinum (DDP)","volume":"21","author":"Arnold DJ","year":"1980","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_23_2","first-page":"421","article-title":"Double\u2010blind comparison of metoclopramide (MCP) and prochlorperazine (PCP) as antiemetics for platinum (CDDP) therapy","volume":"22","author":"Frytak S","year":"1981","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_24_2","first-page":"381","article-title":"Improved control of chemotherapy\u2010induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide","volume":"67","author":"Bruera E","year":"1983","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.289.6449.878-a"},{"key":"e_1_2_1_26_2","first-page":"262","article-title":"Comparison of metoclopramide (M) and metoclopramide and dexamethasone (M + D) in complete prevention of cis\u2010platinum\u2010induced vomiting","volume":"4","author":"Grunberg SM","year":"1985","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.2.245"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00269037"},{"key":"e_1_2_1_29_2","first-page":"263","article-title":"Dexamethasone in the treatment of nausea and vomiting from cancer chemotherapy","volume":"70","author":"Winokur SM","year":"1981","journal-title":"J Med Assoc Ga"},{"key":"e_1_2_1_30_2","first-page":"85","article-title":"A double\u2010blind randomized crossover study comparing high\u2010dose metoclopramide (M) to dexamethasone + prochlorperazine (D + P) as antiemetics during cisplatin chemotherapy (CP)","volume":"2","author":"Hazel GA","year":"1983","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850201)55:3<527::AID-CNCR2820550310>3.0.CO;2-2"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198102193040815"},{"key":"e_1_2_1_33_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/030089168306900107","article-title":"Methylprednisolone as an antiemetic in patients on cis\u2010platinum chemotherapy. Results of a controlled randomized study","volume":"69","author":"Kolaric K","year":"1983","journal-title":"Tumori"},{"key":"e_1_2_1_34_2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/030089168407000306","article-title":"Comparison of methylprednisolone and metoclopramide in the prophylactic treatment of cisplatin\u2010induced nausea and vomiting","volume":"70","author":"Giaconne G","year":"1984","journal-title":"Tumori"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00258123"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1159\/000226063"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.4.320"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198105143042015"}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1986.tb03465.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1875-9114.1986.tb03465.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1875-9114.1986.tb03465.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:18:43Z","timestamp":1761067123000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1002\/j.1875-9114.1986.tb03465.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986,5,6]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1986,5,6]]}},"alternative-id":["10.1002\/j.1875-9114.1986.tb03465.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1875-9114.1986.tb03465.x","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"type":"print","value":"0277-0008"},{"type":"electronic","value":"1875-9114"}],"subject":[],"published":{"date-parts":[[1986,5,6]]},"assertion":[{"value":"2012-01-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}